(Q41340661)

29 September 2017

Central nervous system side-effects with hydrophilic and lipophilic beta-blockers (English)

1 reference

29 September 2017

A Westerlund

1

1 reference

PubMed ID

2865153

29 September 2017

language of work or name

1 reference

1 January 1985

1 reference

European Journal of Clinical Pharmacology

29 September 2017

1 reference

29 September 2017

28 Suppl

1 reference

29 September 2017

73-76

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00543714

29 September 2017

0 references

cites work

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

1 reference

12 December 2020

Controlled study of atenolol in treatment of hypertension

1 reference

12 December 2020

Reduced brain serotonergic activity after repeated treatment with ?-adrenoceptor antagonists

1 reference

12 December 2020

Comparison Between the Acute Hemodynamic Effects and Brain Penetration of Atenolol and Metoprolol

1 reference

12 December 2020

Propranolol psychosis

1 reference

12 December 2020

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

1 reference

12 December 2020

A comparison between atenolol and metoprolol in respect of central nervous system side effects

1 reference

12 December 2020

Long-term Hypotensive Effect of Atenolol (ICI 66.082), a New β-adrenergic Blocking Agent

1 reference

12 December 2020

beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses

1 reference

12 December 2020

Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00543714

1 reference

29 September 2017

1 reference

PubMed ID

2865153